Sutro Biopharma, Inc 10-Q for FY2022 Q2
Sutro Biopharma, Inc. (STRO)
10-Q
2022-08-08
For: 2022-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on August 8, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $28.1M
- up 0.2% from $28.05M a year earlier
- Net loss
- $26.01M
- compared with a net loss of $6.15M a year earlier
- Diluted EPS
- -$0.55
- compared with -$0.13 a year earlier